Gradual decline in mortality rate following STEMI in the United States
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
May 21, 2008 By Vijayalakshmi Kunadian MBBS MD MRCP [1]
World Congress in Cardiology, Argentina: Data presented at the World Congress in Cardiology meeting in Argentina suggests that the age adjusted mortality rate from ST elevation myocardial infarction (STEMI) continues to decline in the United States.
Over the last 20 years, significant advances have been made in the management of patients with acute ST segment elevation myocardial infarction. Data suggesting a decline in mortality following STEMI was presented at the World Congress of Cardiology this week. The data for this analysis were collected from the National Inpatient Sample (NIS) database which is sponsored by the Agency for Healthcare Research and Quality (AHRQ) consisting of information on hospital in-patient admissions from the United States participating in the HCUP from 1988 to 2004. NIS is a component of the Healthcare Cost and Utilization Project (HCUP).
In this study, there were a total of 1,316,216 patients who were admitted with a diagnosis of ST elevation myocardial infarction. The mean (SD) age of the patients was 66.9 (+/- 12.8) years. There were 163,915 deaths in total. From 1988 to 2004, there was a gradual decline in the age adjusted mortality (406.86/100.000, 95% CI 110.25 to 703.49 in 1988 to 286.02/100.00, 95% CI 45.21 to 526.84, p<0.001). The unadjusted mortality declined from 15% in 1988 to 10% in 2004, p<0.01.
Dr Mohaved from University of Arizona Medical Center concluded at the World Congress in Cardiology meeting, Argentina 2008 that the mortality rate following ST elevation myocardial infarction is declining gradually in the United States which reflects the advancement in the strategies available to treat patients with this condition.
Source
- World Congress in Cardiology, Argentina. Presented by Dr Mohaved, Associate Professor of Medicine, University of Arizona Medical Center.
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

